Answer
In clinical trials involving adults with HIV, the most frequently reported adverse reactions to emtricitabine were diarrhoea (14.0%), headache (10.2%), elevated creatine kinase (10.2%) and nausea (10.0%).
Sources for this answer
- Emtriva 200 mg hard capsulesGilead Sciences Ltd · emc · SmPC §4.8 Undesirable effects · Version 31Document updated
Sources checked